Clinical Overview: The PELD Score
The Pediatric End-Stage Liver Disease (PELD) score is the pediatric equivalent of the MELD score. It is specifically calibrated to prioritize children under the age of 12 on the national liver transplant waitlist.
Because children have vastly different physiological baselines and disease presentations than adults (for instance, biliary atresia is the leading cause of pediatric liver failure, whereas cirrhosis drives adult failure), applying adult formulas to infants resulted in profound disparities in organ allocation. The PELD score corrected this inequity.
Pathophysiology and Variables
Like the MELD score, PELD relies on objective markers of liver synthetic function, but it integrates metrics critical to childhood development:
- Age < 1 Year: Infants under 12 months have a statistically higher risk of rapid clinical deterioration and waitlist mortality.
- Growth Failure: A hallmark of severe pediatric chronic illness. If the liver cannot process nutrients, the child's growth velocity plummets. This is measured via height/weight standard deviations.
- Albumin: In children, albumin (a protein made by the liver) is a more accurate predictor of synthetic failure than creatinine.
- Bilirubin & INR: Standard markers of the liver's ability to clear toxins and clot blood.
Formula Breakdown
The PELD formula uses a complex logarithmic calculation to generate a standardized score:
PELD &= 4.80×ln[Bilirubin] \ &\quad + 18.57×ln[INR] \ &\quad - 6.87×ln[Albumin] \ &\quad + [Age/Growth Penalties]
Higher PELD scores directly correlate with a higher risk of 90-day mortality. Just like MELD, UNOS uses these scores to ensure that the most critically ill children receive donor organs first.
Disclaimer: This tool is for educational estimation. Pediatric transplant teams utilize exact pediatric growth curves (CDC/WHO) and specialized exception protocols to manage actual UNOS listings.